Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PORCH: ATG-008 or ATG-010 + Chemotherapy in Gyn Cancers
NCT04998760Phase 2Unknown
- Start
- Aug 2021
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of onatasertib, selinexor in ovarian cancer, endometrial cancer (EC), Cervical Cancer (CC). Status: unknown.
02
Drugs
onatasertibselinexor
03
Conditions
ovarian cancerendometrial cancer (EC)Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT04998760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04998760.